The Nutritional Status of Chemo-radiotherapy Patients

NCT01937273 | Completed

• 1 other identifier: HREC2013 1973
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

Cancer patients are one of the patient groups at highest risk for the development of malnutrition. Anti-cancer treatments, such as chemotherapy and radiotherapy, can further heighten the risk due to the nutrition-related toxicities experienced during this time. This study aims to baseline the nutritional status of chemo-radiotherapy patients undergoing treatment at the Alan Walker Cancer Care Centre (Darwin), identify contributors to nutritional deterioration and determine if there is a difference between Indigenous and non-Indigenous patients.

Conditions

Malnutrition; Cancer

Keywords

Nutritional status, malnutrition, chemo-radiotherapy

Outcome Measures

Primary Outcomes (1)

• The prevalence of malnutrition amongst chemo-radiotherapy patients

  1 year

Secondary Outcomes (1)

• The incidence of the development of malnutrition during chemo-radiotherapy

  1 year

Other Outcomes (2)

• Factors contributing to the development of malnutrition

  1 year

• The difference between Indigenous and non-Indigenous in respect to their nutritional status

  1 year

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults (18 years or over) who are being treated with curative intent chemo-radiotherapy at the Alan Walker Cancer Care Centre during the data collection period

You may qualify if:

• years or over undergoing curative intent chemo-radiotherapy at AWCCC
• Able to speak basic English or have an interpreter present
• Able to provide consent

You may not qualify if:

• Pregnant or breast feeding women
• Non-English speaking background where interpreter not available
• Change to single modality treatment (ie change from chemo-radiotherapy to chemotherapy or radiotherapy alone) or change to treatment intent (ie change from curative intent to palliative intent)
• Violent or aggressive patients to maintain the safety of investigators

Sponsors & Collaborators

• Charles Darwin University: lead

Study Sites (1)

Alan Walker Cancer Care Centre

Darwin, Northern Territory, 0810, Australia

Location

MeSH Terms

Conditions

Malnutrition; Neoplasms

Condition Hierarchy (Ancestors)

Nutrition Disorders; Nutritional and Metabolic Diseases

Study Officials

• Loise Moodie

  Royal Darwin Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 8 Weeks
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 29, 2013
• First Posted: September 9, 2013
• Study Start: June 1, 2013
• Primary Completion: December 1, 2014
• Study Completion: December 1, 2015
• Last Updated: July 16, 2020

Record last verified: 2020-07

Locations

AU (1)